Hoffmann et al. compared [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 in a cohort of patients undergoing PET/CT for primary staging and also found no significant difference in detection rates, concluding that both tracers are equally effective for staging primary prostate cancer [29]. This evidence concerns the gene FOLH1 and prostate cancer.